Advertisement
Canada markets open in 3 hours 49 minutes
  • S&P/TSX

    22,265.05
    -108.35 (-0.48%)
     
  • S&P 500

    5,306.04
    +1.32 (+0.02%)
     
  • DOW

    38,852.86
    -216.74 (-0.55%)
     
  • CAD/USD

    0.7320
    -0.0017 (-0.23%)
     
  • CRUDE OIL

    80.57
    +0.74 (+0.93%)
     
  • Bitcoin CAD

    92,524.27
    -546.37 (-0.59%)
     
  • CMC Crypto 200

    1,458.38
    -26.32 (-1.77%)
     
  • GOLD FUTURES

    2,342.70
    -13.80 (-0.59%)
     
  • RUSSELL 2000

    2,066.85
    -2.82 (-0.14%)
     
  • 10-Yr Bond

    4.5420
    +0.0750 (+1.68%)
     
  • NASDAQ futures

    18,806.25
    -134.25 (-0.71%)
     
  • VOLATILITY

    14.15
    +1.23 (+9.53%)
     
  • FTSE

    8,228.82
    -25.36 (-0.31%)
     
  • NIKKEI 225

    38,556.87
    -298.50 (-0.77%)
     
  • CAD/EUR

    0.6745
    -0.0007 (-0.10%)
     

The Big Mistake I See Cannabis Investors Making Over and Over Again

Pot stocks are a riskier investment
Image source: Getty Images

Written by Adam Othman at The Motley Fool Canada

There’s no doubt that the cannabis industry has plenty of potential upside. With more markets worldwide legalizing cannabis for medicinal or recreational use, companies aiming to target international growth have more opportunities.

Canadian investors interested in cannabis stocks saw a massive boost with the announcement of the Biden administration across the border announcing the decision to classify marijuana as a less dangerous drug. Combined with the news that Germany might legalize marijuana as well, shares of the top TSX marijuana stocks soared.

ADVERTISEMENT

Between April 1 and April 30, 2024, shares of Canopy Growth (TSX:WEED) doubled in price. Between April 29 and April 30, shares of Tilray Brands (TSX:TLRY) climbed 41%. However, going all-in might not be the smartest investment decision despite the seemingly positive news.

Getting too excited for legalization

This is not the first time shares of cannabis companies soared due to legalization announcements. The Canadian cannabis giants saw a massive rise in share prices when the Canadian government made their plans to legalize marijuana in Canada just a few years ago. Many can argue that Canadian investors became too excited and bought too much of the shares in these companies.

As the dust settled and it became clear that these companies did not have the fundamentals to support such high valuations, cannabis stocks came crashing down. There is an inherent volatility in the cannabis industry that investors ignored previously. The recent surge in share prices suggests that they are making the same mistake.

Cannabis reform is not a solid bet

Legalization in Germany might have more solid prospects, but the same cannot be said for the United States. With growing evidence suggesting that marijuana has no place as being classified as a dangerous drug, marijuana reform might be on the horizon. Unfortunately, it might be much further than people think it is.

Canopy Growth, Tilray, and other Canadian cannabis giants will undoubtedly see business soar when the market truly opens up in the United States. However, the development might not come as soon as we think. A reform could just mean that marijuana will become decriminalized across the border.

There is no clear timeline for it to become legalized across the country for recreational use. Legalizing marijuana completely in the U.S. will be an incredibly complex and time-consuming process.

Additionally, there are plenty of hurdles to overcome, including advertising rules, minimum-age requirements, taxes, and the inherent nature of the businesses themselves. Cannabis companies are still burning through cash without reporting significant profits in the domestic market. There might not be much of a change in the cash burn even after new markets open up across the border.

  • We just revealed five stocks as “best buys” this month … join Stock Advisor Canada to find out if Tilray made the list!

Foolish takeaway

Perhaps the biggest point of concern for Canadian investors interested in cannabis stocks due to legalization in the U.S. is the elections. It is important to remember that the Biden administration has made the announcement to reclassify marijuana as a Schedule III substance instead of being in the same category as heroin.

If Donald Trump gets re-elected, it is not impossible for him to completely torpedo the move. Canopy Growth and Tilray, depending on legalization in an uncertain market, should not inspire too much confidence, in my opinion. Investing in Canadian blue-chip stocks in other sectors of the economy might be a safer way to put your capital to work.

The post The Big Mistake I See Cannabis Investors Making Over and Over Again appeared first on The Motley Fool Canada.

Should you invest $1,000 in Tilray Brands right now?

Before you buy stock in Tilray Brands, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tilray Brands wasn’t one of them. The 10 stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $15,578.55!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 32 percentage points since 2013*.

See the 10 stocks * Returns as of 3/20/24

More reading

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends Tilray Brands. The Motley Fool has a disclosure policy.

2024